Edigene Inc.
Beijing, CN· latest recorded location
Edigene Inc. is named on 1 US grants and 12 published applications in this corpus. Its most frequent classification is C12N (Microorganisms or enzymes).
- Granted patents
- 1
- Published applications
- 12
- Inventors
- 33
- Granted in 2026 so far
- 0
- Most recent grant
- 13 Feb 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 0 | 3 |
| 2021 | 0 | 3 |
| 2022 | 0 | 5 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
By publication year.
Technology areas
Share of 13 documents
- C12NMicroorganisms or enzymes13
- A61KMedicines and medical preparations8
- A61PTherapeutic uses of medicines5
- C07KPeptides3
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3
- C40BCombinatorial chemistry3
- C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganisms2
- C12YEnzymes2
- G01NInvestigating or analysing materials by determining their chemical or physical properties1
- G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or1
Recent patents
- Culture medium composition for amplifying and maintaining self-renewal capacity and differentiation potential of hscs and application thereof22 Feb 2024US 2024/0058387 A1
- Method for evaluating gene editing therapy based on off-target assessment27 Oct 2022US 2022/0340969 A1
- Methods and compositions for editing rnas29 Sep 2022US 2022/0307020 A1
- Method for predicting effectiveness of treatment of hemoglobinopathy23 Jun 2022US 2022/0193142 A1
- Method for identifying functional elements16 Jun 2022US 2022/0186210 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.